Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcus Biosciences (RCUS) Preferred Stock Liabilities: 2017

Historic Preferred Stock Liabilities for Arcus Biosciences (RCUS) over the last 1 years, with Dec 2017 value amounting to $226.2 million.

  • Arcus Biosciences' Preferred Stock Liabilities was N/A to $226.2 million in Q4 2017 from the same period last year, while for Dec 2017 it was $226.2 million, marking a year-over-year change of. This contributed to the annual value of $226.2 million for FY2017, which is N/A change from last year.
  • Arcus Biosciences' Preferred Stock Liabilities amounted to $226.2 million in FY2017.
  • In the past 5 years, Arcus Biosciences' Preferred Stock Liabilities registered a high of $226.2 million during FY2017, and its lowest value of $226.2 million during FY2017.
  • For the 1-year period, Arcus Biosciences' Preferred Stock Liabilities averaged around $226.2 million, with its median value being $226.2 million (2017).